CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- 4 Open-market sale CHIEF SCIENTIFIC OFFICER sold 11,250 shares at $40.00 ($450,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 1,000 shares at $31.07 ($31,070)
- 4 Open-market buy Director bought 1,000 shares at $31.00 ($31,000)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 10,000 shares at $30.20 ($302,000)
- 4 Open-market buy PRESIDENT AND CFO bought 3,500 shares at $29.90 ($104,650)
- 4 Open-market sale 10% owner sold 198,572 shares at an average $39.51 ($7,846,426)
- 4 Open-market sale 10% owner sold 5,000 shares at $54.18 ($270,900)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 20,000 shares at $53.35 ($1,066,914)
- 4 Shares withheld for taxes PRESIDENT AND CFO gave up 26,665 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 79,994 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 313,338 shares (to pay taxes)
Page 1 of 15 · 296 filings